https://www.selleckchem.com/pr....oducts/s-gsk1349572.
g., a recurrent GBM tissue) where earlier treatment may have grossly altered the tumor microenvironment. Obese patients are at increased risk of persistent pain and chronic opioid dependence after surgery. We sought to evaluate the impact of an Enhanced Recovery After Surgery (ERAS) protocol in breast surgery patients to determine whether multimodal analgesia was effective for both obese and non-obese patients. A prospective cohort of patients undergoing breast surgery who received an opioid-sparing ERAS protocol was compared with
Like
Comment
Share
